Clinical Trial Update: A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of MY008211A in adult patients with paroxysmal nocturnal hemoglobinuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• MY008211A

Snippet

Sponsor: Wuhan Createrna Science and Technology Co., Ltd | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | Status: COMPLETED